Since 2019, bioMérieux has partnered with the Fleming Fund to provide high medical value diagnostic solutions, innovative data analytics tools and antimicrobial susceptibility testing in 15 countries located in the Africa and Asia Pacific regions.
Swipe to discover more
To mark World Antimicrobial Awareness Week organized by the WHO from November 18-24, bioMérieux presents the results of a bioMérieux/OpinionWay survey on the general public's knowledge of antimicrobial resistance and the use of diagnostic tests in France.
Fighting underlying infections in critically ill or septic patients requires appropriate use of antimicrobials—however, antimicrobials also may exacerbate risk of AKI, C. diff infection, neurotoxicity, or any of a host of potential complications.
For 20 years, bioMérieux and the Hospices Civils de Lyon (HCL) have been collaborating in an innovative public/private research partnership. Joined in 2016 by Claude Bernard Lyon 1 University, the three institutions are working to figure out the mechanisms of immunity in order to develop diagnostic tests.
